| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 27 |
| 1 | UPADACITINIB | 27 |
| 2 | ABATACEPT | 25 |
| 3 | ADALIMUMAB | 25 |
| 4 | ADALIMUMAB-AATY | 25 |
| 5 | BARICITINIB | 25 |
| 6 | TOCILIZUMAB | 25 |
| 7 | ADALIMUMAB-ADAZ | 24 |
| 8 | ADALIMUMAB-FKJP | 24 |
| 9 | EMPAGLIFLOZIN | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 25 | 0.0082 |
| 1 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 2 | LENACAPAVIR SODIUM | 1 | 0.0020 |
| 3 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 4 | SODIUM FLUORIDE F18 | 1 | 0.0009 |
| 5 | SODIUM FLUORIDE F-18 | 1 | 0.0009 |
| 6 | ADALIMUMAB-FKJP | 24 | 0.0005 |
| 7 | ADALIMUMAB-AATY | 25 | 0.0005 |
| 8 | IDURSULFASE | 2 | 0.0005 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 25 | 0.0002 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 25 | 0.0002 |
| 3 | Janus Kinase Inhibitor [EPC] | 27 | 0.0002 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 17 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 6 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 27 | 0.0001 |
| 8 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |